A Subset of Pemphigus Foliaceus Patients Exhibits Pathogenic Autoantibodies Against Both Desmoglein-1 and Desmoglein-3  Luis A. Arteaga, Philip S. Prisayanh,

Slides:



Advertisements
Similar presentations
Donna A. Culton, Suzanne K. McCray, Moonhee Park, James C
Advertisements

Journal of Allergy and Clinical Immunology
Christoph M. Hammers, Jing Chen, Chenyan Lin, Stephen Kacir, Don L
The Autoantigen in Anti-p200 Pemphigoid Is Synthesized by Keratinocytes and Fibroblasts and Is Distinct from Nidogen-2  Silke C. Hofmann, Ursula Voith,
Bullous Pemphigoid: Using Animal Models to Study the Immunopathology
MAPKAP Kinase 2 (MK2)-Dependent and -Independent Models of Blister Formation in Pemphigus Vulgaris  Xuming Mao, Hong Li, Yasuyo Sano, Matthias Gaestel,
Bullous Pemphigoid Sera that Contain Antibodies to BPAg2 also Contain Antibodies to LABD97 that Recognize Epitopes Distal to the NC16A Domain  Conleth.
Activation-Dependent Modulation of Hyaluronate-Receptor Expression and of Hyaluronate-Avidity by Human Monocytes  Johannes M. Weiss, Andreas C. Renkl,
A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180  Manabu Osawa, MD, Ikuko Ueda-Hayakawa, MD, PhD, Taiki.
Peptidylarginine Deiminase Isoforms 1–3 Are Expressed in the Epidermis and Involved in the Deimination of K1 and Filaggrin  Rachida Nachat, Marie-Claire.
Antibody Phage Display: Technique and Applications
Pathogenic Epitopes of Autoantibodies in Pemphigus Reside in the Amino-Terminal Adhesive Region of Desmogleins Which Are Unmasked by Proteolytic Processing.
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies  Ellen Toyonaga, Wataru Nishie, Kentaro Izumi, Ken.
Epitopes in the Linker Subdomain Region of Envoplakin Recognized by Autoantibodies in Paraneoplastic Pemphigus Patients  Bingxin Zhang, Rui Zheng, Jing.
Yasushi Hanakawa, Trevor Selwood, Denise Woo, Chenyan Lin, Norman M
Aimee S. Payne, Don L. Siegel, John R. Stanley 
Xiang Ding, Luis A. Diaz, Janet A. Fairley, George J. Giudice, Zhi Liu 
Targeted Delivery of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand to Keratinocytes with a Pemphigus mAb  Michiyoshi Kouno, Chenyan Lin, Norman.
The IgM Anti-Desmoglein 1 Response Distinguishes Brazilian Pemphigus Foliaceus (Fogo Selvagem) from Other Forms of Pemphigus  Luis A. Diaz, Phillip S.
Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients  Atsunari Tsuchisaka, Sanae Numata, Kwesi.
Induction of Epidermolysis Bullosa Acquisita in Mice by Passive Transfer of Autoantibodies from Patients  David T. Woodley, Ramin Ram, Arvin Doostan,
Isolation of Pathogenic Monoclonal Anti-Desmoglein 1 Human Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies  Ken Ishii, Chenyan Lin,
Synergistic Pathogenic Effects of Combined Mouse Monoclonal Anti-Desmoglein 3 IgG Antibodies on Pemphigus Vulgaris Blister Formation  Hiroshi Kawasaki,
Paraneoplastic Pemphigus Sera React Strongly with Multiple Epitopes on the Various Regions of Envoplakin and Periplakin, Except for the C-Terminal Homologous.
Anti-Desmoglein-1 Antibodies in Onchocerciasis, Leishmaniasis and Chagas Disease Suggest a Possible Etiological Link to Fogo Selvagem  Luis A. Diaz, Luis.
Autoantibodies in a Subgroup of Patients with Linear IgA Disease React with the NC16A Domain of BP1801  Detlef Zillikens, Karin Herzele, Matthias Georgi,
Evidence that Anti-Type VII Collagen Antibodies Are Pathogenic and Responsible for the Clinical, Histological, and Immunological Features of Epidermolysis.
Function Blocking Autoantibodies Against Matrix Metalloproteinase-1 in Patients with Systemic Sclerosis  Shinichi Sato, Ikuko Hayakawa, Minoru Hasegawa,
Modes of Action of Intravenous Immunoglobulin in Bullous Pemphigoid
Identification of Desmogleins as Disease Targets
In Vitro Keratinocyte Dissociation Assay for Evaluation of the Pathogenicity of Anti- Desmoglein 3 IgG Autoantibodies in Pemphigus Vulgaris  Ken Ishii,
Pemphigus Vulgaris and Pemphigus Foliaceus Antibodies are Pathogenic in Plasminogen Activator Knockout Mice  My G. Mahoney, Zhi Hong Wang, John R. Stanley 
IgE Anti-LJM11 Sand Fly Salivary Antigen May Herald the Onset of Fogo Selvagem in Endemic Brazilian Regions  Ye Qian, Joseph S. Jeong, Maha Abdeladhim,
Autoantibodies to Bullous Pemphigoid Antigen 180 Induce Dermal–Epidermal Separation in Cryosections of Human Skin  Cassian Sitaru, Enno Schmidt, Steffen.
Detection of IgG Autoantibodies in the Sera of Patients with Bullous and Gestational Pemphigoid: ELISA Studies Utilizing a Baculovirus-Encoded Form of.
Prevalence of Antibodies Against Virus-Like Particles of Epidermodysplasia Verruciformis-Associated HPV8 in Patients at Risk of Skin Cancer  Sabine Stark,
Pathogenic Anti-Desmoglein 3 mAbs Cloned from a Paraneoplastic Pemphigus Patient by Phage Display  Marwah A. Saleh, Ken Ishii, Jun Yamagami, Yuji Shirakata,
BP230- and BP180-specific Auto-Antibodies in Bullous Pemphigoid
Identification of a Potential Effector Function for IgE Autoantibodies in the Organ- Specific Autoimmune Disease Bullous Pemphigoid  Otobia G. Dimson,
Cloning of Hamster Type XVII Collagen cDNA, and Pathogenesis of Anti-Type XVII Collagen Antibody and Complement in Hamster Bullous Pemphigoid  Katsushi.
Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid  Kentaro Izumi, Wataru Nishie, Yosuke Mai, Mayumi Wada,
The Members of the Plakin Family of Proteins Recognized by Paraneoplastic Pemphigus Antibodies Include Periplakin  My G. Mahoney, Sirpa Aho, Jouni Uitto,
Masaki Nagai, Minoru Hasegawa, Kazuhiko Takehara, Shinichi Sato 
Erythema Multiforme Associated Human Autoantibodies Against Desmoplakin I and II: Biochemical Characterization and Passive Transfer Studies Into Newborn.
The Intracellular and Extracellular Domains of BP180 Antigen Comprise Novel Epitopes Targeted by Pemphigoid Gestationis Autoantibodies  Giovanni Di Zenzo,
IgG Autoantibodies from Bullous Pemphigoid (BP) Patients Bind Antigenic Sites on Both the Extracellular and the Intracellular Domains of the BP Antigen.
Anti-Alpha-2-Macroglobulin-Like-1 Autoantibodies Are Detected Frequently and May Be Pathogenic in Paraneoplastic Pemphigus  Sanae Numata, Kwesi Teye,
Pathogenicity and Epitope Characteristics of Anti-Desmoglein-1 from Pemphigus Foliaceus Patients Expressing Only IgG1 Autoantibodies  Mary K. Hacker-foegen,
The Thomsen-Friedenreich Antigen-Binding Lectin Jacalin Interacts with Desmoglein-1 and Abrogates the Pathogenicity of Pemphigus Foliaceus Autoantibodies.
The Prevalence and Clinical Significance of Anti-U1 RNA Antibodies in Patients with Systemic Sclerosis  Yoshihide Asano, Hironobu Ihn, Kenichi Yamane,
Production of Low Titers of Anti-Desmoglein 1 IgG Autoantibodies in Some Patients with Staphylococcal Scalded Skin Syndrome  Hidemi Anzai, John R. Stanley,
Julio Hilario-Vargas, David A
Autoantibody in Mucous Membrane Pemphigoid Binds to an Intracellular Epitope on Human β4 Integrin and Causes Basement Membrane Zone Separation in Oral.
Autoantibodies in Vitiligo Patients Recognize Multiple Domains of the Melanin- Concentrating Hormone Receptor  Raju V.S.R.K. Gottumukkala, Elizabeth A.
Autoantibodies to BP180 Associated with Bullous Pemphigoid Release Interleukin-6 and Interleukin-8 from Cultured Human Keratinocytes  Enno Schmidt, Stanislaus.
IgG Autoantibodies from Bullous Pemphigoid Patients Recognize Multiple Antigenic Reactive Sites Located Predominantly Within the B and C Subdomains of.
Valeria Aoki, Robert C. Millikan, Evandro A
Janet A. Fairley, Chang Ling Fu, George J. Giudice 
Immunological and Statistical Studies of Anti-BP180 Antibodies in Paraneoplastic Pemphigus  Atsunari Tsuchisaka, Hideo Kawano, Atsushi Yasukochi, Kwesi.
Detection of Laminin 5-Specific Auto-antibodies in Mucous Membrane and Bullous Pemphigoid Sera by ELISA  Vassiliki Bekou, Sybille Thoma-Uszynski, Olaf.
Severity and Phenotype of Bullous Pemphigoid Relate to Autoantibody Profile Against the NH2- and COOH-Terminal Regions of the BP180 Ectodomain  Silke.
No Evidence of Human Herpesvirus 8 Infection in Patients with Paraneoplastic Pemphigus, Pemphigus Vulgaris, or Pemphigus Foliaceus  Sandra S. Cohen, Andrew.
S.J.P. Warren, L.A. Arteaga, L.A. Diaz 
Flor Evangelista, David A. Dasher, Luis A. Diaz, Phillip S
Envoplakin and Periplakin, the Paraneoplastic Pemphigus Antigens, are also Recognized by Pemphigus Foliaceus Autoantibodies  Shideh Kazerounian, Mỹ G.
Staphylococcal Exfoliative Toxin B Specifically Cleaves Desmoglein 1
Antigen Selection of Anti-DSG1 Autoantibodies During and Before the Onset of Endemic Pemphigus Foliaceus  Ye Qian, Stephen H. Clarke, Valeria Aoki, Gunter.
IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid  Zelmira Lazarova, MD, Valerie.
Zhuxiang Nie, Takashi Hashimoto  Journal of Investigative Dermatology 
Presentation transcript:

A Subset of Pemphigus Foliaceus Patients Exhibits Pathogenic Autoantibodies Against Both Desmoglein-1 and Desmoglein-3  Luis A. Arteaga, Philip S. Prisayanh, Simon J.P. Warren, Zhi Liu, Luis A. Diaz, Mong-Shang Lin  Journal of Investigative Dermatology  Volume 118, Issue 5, Pages 806-811 (May 2002) DOI: 10.1046/j.1523-1747.2002.01743.x Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Molecular structure of the extra cellular region of dsg1 and dsg3. dsg1 and dsg3 exhibit five major cadherin-like domains (EC-1, EC-2, EC-3, EC-4, and EC-5), stretching from the N-terminus (EC-1) to the C-terminus (transmembrane domain). The six-histidine tag is attached to the C-terminus. The black strips represent Ca2+ binding motifs. The recombinant ectodomains of rdsg1 and rdsg3 are expressed in the baculovirus system as a soluble glycopeptide of approximately 66 kDa. Journal of Investigative Dermatology 2002 118, 806-811DOI: (10.1046/j.1523-1747.2002.01743.x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Sera from PV patients specifically react with rdsg3 using the dsg3 ELISA. The cut-off value for this assay was set at the mean of 50 normal human sera plus 3 SD, equal to 0.48 OD units. All 50 normal sera were negative, as were 20 patients with bullous pemphigoid (BP), 19 with systemic lupus erythematosus (SLE), and 23 with herpes gestationis (HG). Eighty-two of 83 patients with PV were positive. The one PV patient that was negative was also in clinical remission. Journal of Investigative Dermatology 2002 118, 806-811DOI: (10.1046/j.1523-1747.2002.01743.x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 All 19 patients with antibodies to dsg3 by ELISA were also positive by immunoprecipitation. The autoradiogram shows immunoprecipitates analyzed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis. Lane P: PV patient included as a positive dsg3 control. Lane C: Normal human serum included as a negative control. Lanes 1–19: All 19 patients with PF or FS with antibodies to dsg3 by ELISA. Journal of Investigative Dermatology 2002 118, 806-811DOI: (10.1046/j.1523-1747.2002.01743.x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 Competitive inhibition of the dsg1 and dsg3 ELISA by soluble recombinant dsg1 and dsg3. PF or FS serum was incubated with rdsg1 or rdsg3 (0–8 µg) and then tested in the dsg1 and dsg3 ELISA. (A) Purified rdsg3 was capable of absorbing anti-dsg3 activity, but not anti-dsg1 activity. (B) Purified rdsg1 was capable of absorbing ant-dsg1 activity but not anti-dsg3 activity. The asterisk sign indicates that the ELISA titers of samples are below the cut-offs. Journal of Investigative Dermatology 2002 118, 806-811DOI: (10.1046/j.1523-1747.2002.01743.x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Anti-dsg1 and anti-dsg3 autoantibody fractions from patients with PF and FS are pathogenic. Neonatal BALB/C mice were injected intradermally with affinity purified anti-dsg1 autoantibodies (A–C) or anti-dsg3 autoantibodies (D–F), respectively. The clinical, immunologic, and histologic evaluations were performed 18 h post-IgG injection. Mice injected with anti-dsg1 autoantibodies developed blisters (A), which were located in the subcorneal region of the epidermis (B). The anti-dsg1 autoantibodies were detected bound to the epidermal ICS by direct IF (C). Mice injected with anti-dsg3 autoantibodies developed blisters (D), which were located in the suprabasilar region of the epidermis (E). Autoantibodies were detected bound to the epidermal ICS by direct IF (F). The pathogenicity of the anti-dsg3 and anti-dsg1 autoantibodies fractions was blocked by preincubation of these fractions with purified rdsg3 and rdsg1, respectively (data not shown). Journal of Investigative Dermatology 2002 118, 806-811DOI: (10.1046/j.1523-1747.2002.01743.x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 The purified total IgG fraction from PF and FS patients with antibodies to both dsg1 and dsg3 produce clinical and histologic features of PF in the mouse model. The total IgG fraction from two patients with endemic PF and one with nonendemic PF were purified by ammonium sulfate precipitation and injected intradermally into neonatal mice. All three sera reproduced the clinical (A) and histologic features (B) of PF, namely superficial blistering with subcorneal acantholysis. Journal of Investigative Dermatology 2002 118, 806-811DOI: (10.1046/j.1523-1747.2002.01743.x) Copyright © 2002 The Society for Investigative Dermatology, Inc Terms and Conditions